Health Canada re: Food and Drug Act with respect to Progressive Licensing Framework
Industry Canada re: Patent Act with respect to pharmaceutical patents
Policies or Program
Health Canada re: Canadian Agency for Drugs and Technology in Health (Common Drug Review) concerning the implementation of Standing Committee recommendations in respect of patient input, special mechanism for first in class orphan drugs, and an appeal mechanism
Health Canada re: Food and Drug Act Guidance with respect to interpretation of requirements for pharmaceuticals
Health Canada re: National Pharmaceutical Strategy concerning National Orphan Drug Policy for rare disorders
Health Canada re: National Pharmaceutical Strategy, Regulatory Approval, Health Canada
Industry Canada re: "Mobilizing Science and Technology to Canada's Advantage" to provide concrete recommendations on how the policy should be fleshed out in terms of macroeconomic levels to encourage innovation
Industry Canada re: Patent Act guidance (Patented Medicines Price Review Board Guidance) concerning data exclusivity in respect of biologics
Innovation Strategy re: pharmaceutical products
Regulation
Health Canada re Patented Medicines (Notice of Compliance) Regulations concerning data exclusivity in respect of biologics
Health Canada re: Food and Drug Act Regulations with respect to Progressive Licensing Framework
Industry Canada re: Patent Act Regulations concerning the Patented Medicines Price Review Board